CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,000 | -76.3% | 11,110 | -67.7% | 0.00% | -50.0% |
| Q4 2021 | $93,000 | -95.2% | 34,431 | -89.6% | 0.00% | -94.4% |
| Q2 2021 | $1,920,000 | +879.6% | 331,063 | +1088.0% | 0.04% | +800.0% |
| Q1 2021 | $196,000 | +142.0% | 27,867 | +133.5% | 0.00% | 0.0% |
| Q2 2020 | $81,000 | -88.3% | 11,934 | -82.1% | 0.00% | -87.1% |
| Q4 2019 | $695,000 | -13.2% | 66,634 | +23.7% | 0.03% | +34.8% |
| Q2 2019 | $801,000 | +100.8% | 53,849 | +817.7% | 0.02% | +130.0% |
| Q4 2017 | $399,000 | +50.0% | 5,868 | -57.7% | 0.01% | +42.9% |
| Q1 2016 | $266,000 | -96.6% | 13,858 | -93.8% | 0.01% | -96.8% |
| Q4 2015 | $7,875,000 | +1972.4% | 225,000 | +5346.6% | 0.22% | +1600.0% |
| Q3 2015 | $380,000 | – | 4,131 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |